221 related articles for article (PubMed ID: 9371620)
1. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.
Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J
J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
4. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
5. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
[TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
[TBL] [Abstract][Full Text] [Related]
9. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I
Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565
[TBL] [Abstract][Full Text] [Related]
10. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
11. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis.
Heinz FX; Allison SL; Stiasny K; Schalich J; Holzmann H; Mandl CW; Kunz C
Vaccine; 1995 Dec; 13(17):1636-42. PubMed ID: 8719513
[TBL] [Abstract][Full Text] [Related]
12. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
13. Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.
VanBlargan LA; Errico JM; Kafai NM; Burgomaster KE; Jethva PN; Broeckel RM; Meade-White K; Nelson CA; Himansu S; Wang D; Handley SA; Gross ML; Best SM; Pierson TC; Fremont DH; Diamond MS
J Exp Med; 2021 May; 218(5):. PubMed ID: 33831142
[TBL] [Abstract][Full Text] [Related]
14. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
[TBL] [Abstract][Full Text] [Related]
15. Potential use of attenuated langat E5 virus as a live vaccine -- long term protection against Russian spring-summer encephalitis virus in mice.
Thind S
J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):155-62. PubMed ID: 6265549
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
Chidumayo NN; Yoshii K; Kariwa H
Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
[TBL] [Abstract][Full Text] [Related]
19. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
Morozova OV; Maksimova TG; Bakhvalova VN
Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
[TBL] [Abstract][Full Text] [Related]
20. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX
J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
